Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer

Breast cancer (BC) is the leading cause of death among female patients with cancer. Patients with triple-negative breast cancer (TNBC) have the lowest survival rate. TNBC has substantial heterogeneity within the BC population. This study utilized our novel patient stratification and drug repositioni...

Full description

Bibliographic Details
Main Authors: Zainab Al-Taie, Mark Hannink, Jonathan Mitchem, Christos Papageorgiou, Chi-Ren Shyu
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
subgrouping
patient stratification
triple negative breast cancer
ferroptosis
antioxidant
drug repositioning
Online Access:https://www.mdpi.com/2072-6694/13/24/6278

Internet

https://www.mdpi.com/2072-6694/13/24/6278

Similar Items